Arguments Against HPV Vaccines

One of the Healthy People 2020 initiatives or goals that I want to discuss is sexually transmitted diseases. According to Healthy People 2020 (2015) their goal is to “promote healthy sexual behaviors, strengthen community capacity, and increase access to quality services to prevent sexually transmitted diseases (STDs) and their complications.” One of their objectives in this area is to reduce HPV (human papillomavirus) infections females. I would hope to reduce the incidence of this infection by promoting safe sex, health screenings and immunizations to adolescent and adult women. Certain subtypes of HPV can lead to cervical cancer and anogenital warts (Pomfret, Gagnon Jr, & Gilchrist, 2011).

Human papillomavirus (HPV) infection is a widespread sexually transmitted infection. Approximately 14 million Americans are infected with HPV each year ("HPV Vaccine for Preteens and Teens,"). HPV also causes several types of cancers, such as vaginal cancer and anal cancer. More than 27,000 women and men are affected by a HPV-related cancer annually ("The Link Between HPV and Cancer,"). The most common HPV cancers for women and men are cervical cancer, and oral cavity and oropharyngeal cancers, respectively. Research has demonstrated that many cancers caused by HPV can be prevented by the HPV vaccine, which is administered in 3 doses over 6 months ("The

The HPV virus has gone unseen by many until the recent controversy over the vaccine. However, this virus is thought to be one of the world’s most wide spread STD’s. “According to the Centers for Disease Control and Prevention (CDC), about 6.2 million women and men are newly infected every year” with HPV. HPV has over 100 strains, with more than thirty that are sexually transmitted. Some of these strains are known to cause cervix, vulva, vagina, anus, or penis cancers and others can cause genital warts. “Studies have found the vaccine to be almost 100% effective in preventing diseases caused by the four HPV types covered by the vaccine—including precancers of the cervix, vulva and vagina, and genital warts” (“HPV Questions and

HPV is the number one sexually transmitted infection (STI) in the United States, and anyone who is sexually active is at risk of contracting the virus. HPV is transmitted through intimate skin-to-skin contact with someone who has the virus, and it is so common that most all sexually active men and women encounter a strain without ever knowing they’re infected (CDC). There are many strains of the HPV virus, some of which don’t cause cervical cancer. To help understand and classify the types of HPV, the terms low-risk and high-risk HPV are used. Some

Human Papillomavirus (HPV) is a double -stranded deoxyribonucleic acid (DNA) virus that only infects humans with an attraction to both cutaneous and mucosal surfaces such as the cervix, anus, tonsil, and oropharynx (Clark, 2013). HPV is a type of oncogenic virus that goes into the cells and can cause several diseases. Over the years, research has surfaced connecting genital HPV to several types of cancer. There are over a hundred strains of HPV but the most high risk strains, 16 and 18, have been shown to cause vulvar, vaginal, anal, and the most concerning, cervical cancer (Chan, Ng, & Wong, 2012). Genital HPV

HPV Virus is responsible for more than 70% of vulvar and vaginal cancers and 90% of cervical and anal cancers.Statistics reveal 33,200 HPV related cancers are reported in the United States each year(CDC,2014). There is no treatment for HPV virus infections as the natural immunity will clear the virus from the body over time. However there are ways to prevent the infection by preventive measures like condoms and vaccines to prevent cervical cancer in high risk individuals. There are two HPV vaccines mainly Gardasil and Cervarix which provide protection against HPV infection. HPV vaccines are recommended for boys and girls in the ages of 11 to 12 years as well as for

HPV is a class of more than 150 related viruses. Each HPV virus in this vast body receives a number which is called its HPV type. HPV is termed for warts (papillomas) some HPV types can cause. Some other HPV types can lead to cancer. HPV cancers consist of cancer of the cervix, vulva, vagina, penis, or anus. HPV infection can also cause cancer in the

In men, the failure to use a condom is associated with HPV infection. (Hippeläinen et al. 1993). One study found that condom use did not protect women from HPV infection, although another study concluded that condoms did have a protective effect. (Slattery et al. 1989). Perhaps there have been controversies regarding the use of oral contraceptive. This issue is important due to an increase of HPV infection in women. In the study with women using condylomata contraceptive had no effect between oral contraceptive HPV infection. (Kataja et al. 1993). However, in another study findings with the association between oral contraceptive and HPV infection were that contraceptives act by altering disease progression in individuals and did increase the risk of HPV infection. (BP Negrini, MH Schiffman, RJ

Education is the key to preventing HPV infections. It is essential to educate the people to get vaccinated and to get their recommended screenings to reduce their risk of cancers caused by HPV infection. Vaccination programs are the most cost-effective public health intervention to prevent HPV infections. Although condoms do not fully protect them from acquiring the HPV infections, the use of condoms can reduce their risk and should be made available. Lastly, the best way to prevent HPV infections is by educating them to avoid sexual intercourse and any skin to skin

The term cancer evokes a great fear in many because there has yet been a cure found for the disease. Human papillomavirus (HPV) is a pathogen that can cause cancer. HPV is one of the few cancer causing pathogens that has a vaccination that is already being administered to the general public. The administering of this vaccine would prevent millions of people from becoming infected. Each year about 14 million men and women are infected with the human papillomavirus, though many could be prevented. HPV is a widely contractible virus that can yield cancerous effects, but it is largely preventable via proper vaccination.

In addition, the immune system of most women will usually suppress or eliminate HPVs. This is very important because only an ongoing persistent infection has the potential to lead to cervical cancer (HPV). Eleven thousand cases of this kind of cancer were confirmed in 2007 in the United States; the amount undiagnosed is still unclear but believed to be in the tens of thousands. But to give some perspective of the problem you need to understand its effects on a global level. On the world wide scale cervical cancer strikes nearly half a million women each year, claiming more than a quarter of a million lives. “High risk” HPV types 16 and 18 are implicated in Seventy percent of cervical cancers and are hence selected for vaccine targets (The HPV).

In recent years, medical experts and public health advocates have increasingly become concerned about the growing underutilization of the HPV vaccination in the United States. While most agree that the issue deserves attentions, consensus dissolves around how to respond to the problem. This literature review examines the background of HPV, several approaches to ensuring that HPV vaccinations utilized. This paper also compares effectiveness, for females ages 12-26, of strategies and of the only vaccination approved by the Food and Drug Administration (FDA) for long term prevention of HPV, as well as consequent diseases/illnesses.

How to Improve the Effects of the HPV Vaccines Reduced Cost of Vaccines As of 2016, there is 10 years’ worth of data describing the impacts of the HPV vaccine. The majority of the literature on the topic of HPV takes place from 2006 at the initial release of the vaccine and continues to follow the effects of the vaccine until the present. The vaccine is viewed as extremely effective and much of the current research focuses on how to increase uptake in high-income countries as well as provide better access to the vaccine on a global scale. Research concludes that while the vaccine is effective at decreasing rates of HPV and HPV-associated illnesses, the overall uptake of the vaccine is less than optimal. Research shows a 90% reduction for HPV types 6, 11, 16, and 18, approximately 90% decrease in genital warts, and 85% reduction in high-risk cervical abnormalities.

Being the 50 percent of sexually active people will have genital hpv in their lifetime the Human papilloma virus is the most common sexually transmitted virus in the United States of America.There are two vaccines that are currently available to prevent the Human papilloma virus that cause the most cervical cancers.The vaccines are Cervarix and Gardasil which also treats genital warts as well as anal and vaginal cancers. No federal laws yet mandate vaccinations but all states require certain vaccinations for children entering public schools. The human papilloma virus vaccine prevents infection with certain species of human papilloma virus associated with the development of cervical cancer and genital warts. The

The most important risk factor in acquiring cervical cancer is the Human Papillomavirus (HPV) types 16 and 18, which are commonly transmitted through sexual contact. Cervical cancer is also caused by other contributing factors such as smoking, familial history, low intake of food that boost immune system and multiple sexual partners.